This Fool wants to make the most of the benefits a Stocks and Shares ISA provides. He's keen on these two stocks.

Constellation Energy and Vistra have been among the best-performing stocks this year, reflecting optimism around the companies' potential to capitalize on the power needs of artificial-intelligence ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

In the past 60 days, estimates for Krystal Biotech’s 2024 EPS have increased from $2.09 to $2.38. The consensus estimate for 2025 earnings has improved from $4.33 to $7.31. Year to date, shares of ...

Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving ...

Check Out These 3 Stocks Executives Are Buying Galmed Pharmaceuticals is a very low-float stock with approximately 625,000 ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

Kacholia turned heads when he exited these stocks between December 2023 and June 2024. Was it a mistake or will his decision ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...